` Comparison: BM8 vs GILD - Alpha Spread

BM8
vs
GILD

Over the past 12 months, BM8 has underperformed GILD, delivering a return of -23% compared to the GILD's +26% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
BM8
GILD
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

BM8 Intrinsic Value
73.35 EUR
Undervaluation 31%
Intrinsic Value
Price
GILD Intrinsic Value
115.68 USD
Overvaluation 20%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Biomarin Pharmaceutical Inc
XBER:BM8
50.68 EUR
Gilead Sciences Inc
NASDAQ:GILD
144.78 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
BM8, GILD

BM8
GILD
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Biomarin Pharmaceutical Inc
Revenue
Gilead Sciences Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
BM8, GILD

BM8
GILD
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Biomarin Pharmaceutical Inc
XBER:BM8
Gilead Sciences Inc
NASDAQ:GILD
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

BM8
81.4%
GILD
78.8%

Operating Margin

BM8
27.1%
GILD
40%

Net Margin

BM8
10.8%
GILD
28.9%

FCF Margin

BM8
22.3%
GILD
32.1%

ROE

BM8
5.9%
GILD
40.5%

ROA

BM8
4.8%
GILD
14.4%

ROIC

BM8
11.1%
GILD
21.4%

ROCE

BM8
13.2%
GILD
25%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
BM8, GILD

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BM8, GILD

Loading
BM8
GILD
Difference
www.alphaspread.com

Performance By Year
BM8, GILD

Loading
BM8
GILD
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare BM8 to other stocks
EPE
Epizyme Inc
E
More expensive
vs BM8
PNEXF
Pharnext SCA
More expensive
vs BM8
ABBV
Abbvie Inc
More expensive
vs BM8
AMGN
Amgen Inc
More expensive
vs BM8
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett